<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>235-FLUOROURACIL-(AND,-BY-EXTRAPOLATION,-OTHER-FLUOROPYRIMIDINES).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="FLUOROQUINOLONES" code="J01MA-001" /></DRUG1>
<DRUG2>
<CLASS name="VITAMIN K ANTAGONISTS" code="B01AA-001" /></DRUG2>
<DESCRIPTION>Increase of the effect of the vitamin K antagonist and of the risk of hemorrhage</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>More frequent testing of the INR. Possible adjustment of the dosage of the vitamin K antagonist during the treatment with the fluoroquinolone and after it is stopped.</COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>235-FLUOROURACIL-(AND,-BY-EXTRAPOLATION,-OTHER-FLUOROPYRIMIDINES).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="FLUOROQUINOLONES" code="J01MA-001" /></DRUG1>
<DRUG2>
<DRUG name="IRON" rxcui="1431589">
<ATC code="B03A" />
</DRUG>
</DRUG2>
<DESCRIPTION>Decrease of the digestive absorption of the fluoroquinolones</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Take the iron salts at a different time from the fluoroquinolones (more that 2 hours apart if possible).</COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>235-FLUOROURACIL-(AND,-BY-EXTRAPOLATION,-OTHER-FLUOROPYRIMIDINES).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="FLUOROQUINOLONES" code="J01MA-001" /></DRUG1>
<DRUG2>
<CLASS name="GLUCOCORTICOIDS (EXCEPT HYDROCORTISONE)" code="A0-H0-001" /></DRUG2>
<DESCRIPTION>Possible increase of the risk of tendinitis, even of rupture of the tendon (exceptional), particularly in patients receiving prolonged corticotherapy </DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>235-FLUOROURACIL-(AND,-BY-EXTRAPOLATION,-OTHER-FLUOROPYRIMIDINES).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="FLUOROQUINOLONES" code="J01MA-001" /></DRUG1>
<DRUG2>
<DRUG name="MYCOPHENOLATE MOFETIL" >
<ATC code="MYCOPHEN" />
<ATC code="OLIC" />
<ATC code="ACID" />
<ATC code="MYCOPHEN" />
<ATC code="OLATE" />
<ATC code="MOFETIL" />
<ATC code="MYCOPHEN" />
<ATC code="OLIC" />
<ATC code="ACID" />
<ATC code="MYCOPHEN" />
<ATC code="OLIC" />
<ATC code="ACID" />
<ATC code="7145" />
<ATC code="L04AA06" />
</DRUG>
</DRUG2>
<DESCRIPTION>Decrease of the concentrations of the mycophenolic acid by about a third, with potential risk of reduction of effectiveness. </DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>235-FLUOROURACIL-(AND,-BY-EXTRAPOLATION,-OTHER-FLUOROPYRIMIDINES).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="FLUOROQUINOLONES" code="J01MA-001" /></DRUG1>
<DRUG2>
<DRUG name="STRONTIUM" rxcui="81638">
<ATC code="V10BX01" />
<ATC code="M05BX03" />
</DRUG>
</DRUG2>
<DESCRIPTION>Decrease of the digestive absorption of the strontium</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Take the strontium at a different time from the fluoroquinolones (more than two hours apart if possible).</COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>235-FLUOROURACIL-(AND,-BY-EXTRAPOLATION,-OTHER-FLUOROPYRIMIDINES).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="FLUOROQUINOLONES" code="J01MA-001" /></DRUG1>
<DRUG2>
<DRUG name="SUCRALFATE" rxcui="10156">
<ATC code="A02BX02" />
</DRUG>
</DRUG2>
<DESCRIPTION>Decrease of the digestive absorption of the fluoroquinolones</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Take the sucralfate at a different time from the fluoroquinolone (more than 2 hours apart if possible).</COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>235-FLUOROURACIL-(AND,-BY-EXTRAPOLATION,-OTHER-FLUOROPYRIMIDINES).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="FLUOROQUINOLONES" code="J01MA-001" /></DRUG1>
<DRUG2>
<DRUG name="ZINC" rxcui="1431163">
<ATC code="A12CB" />
<ATC code="A12CB01" />
<ATC code="A12CB02" />
<ATC code="A12CB03" />
<ATC code="B05X" />
<ATC code="B05XA" />
<ATC code="B05XA12" />
<ATC code="B05XA12" />
<ATC code="B05XA12" />
<ATC code="B05XA12" />
<ATC code="B05XA12" />
<ATC code="B05XA12" />
<ATC code="B05XA12" />
<ATC code="B05XA12" />
<ATC code="B05XA12" />
<ATC code="B05XA12" />
<ATC code="B05XA12" />
<ATC code="B05XA12" />
<ATC code="B05XA12" />
<ATC code="B05XA12" />
</DRUG>
</DRUG2>
<DESCRIPTION>Decrease of the digestive absorption of the fluoroquinolones</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Take the zinc salts at a different time from the fluoroquinlones (more than 2 hours apart if possible).</COMMENT>
</INTERACTION>
</INTERACTIONS>
